Zusammenfassung
Seit der Einführung der Neuroleptika gibt es keinen Zweifel an der therapeutischen Beeinflußbarkeit der produktiv-psychotischen Symptomatik der Schizophrenie. Dagegen fand die Frage, wie stabil oder instabil die sogenannte schizophrene Minussymptomatik ist, erst in den letzten zehn bis 15 Jahren die der Problematik angemessene Aufmerksamkeit in der Schizophrenieforschung. Von besonderer Relevanz ist diese Frage für die Entwicklung neuerer Neuroleptika geworden, von denen auch ein günstiger Effekt auf Affektverflachung, Antriebsmangel und sozialen Rückzug erwartet wird.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders (DSM-III-R). American Psychiatric Association, Washington DC
Andreasen NC (1982) Negative symptoms in schizophrenia: definition and reliability. Arch Gen Psychiatry 39: 784–788
Andreasen NC, Flaum M, Arndt S, Alliger R, Swayze VW (1991) Positive and negative symptoms: assessment and validity. In: Marneros A, Andreasen NC, Tsuang MT (eds) Negative versus positive schizophrenia. Springer, Berlin Heidelberg New York Tokyo, pp 28–52
Arndt S, Alliger R, Andreasen NC (1991) The distinction of positive and negative symptoms. Br J Psychiatry 158: 317–322
Bilder RM, Sukdeb M, Rieder RO, Pandurangi AK (1985) Symptomatic and neuropsychological components of defect states. Schizophr Bull 11: 409–417
Carpenter WT, Heinrichs DW, Wagman AMI (1988) Deficit and nondeficit forms of schizophrenia: the concept. Am J Psychiatry 145: 578–583
Crow TJ (1980) Molecular pathology of schizophrenia: more than one disease process? Br Med J 280: 66–68
Feinberg S, Kay S, Elijovich L, Fiszbein A, Opler L (1988) Pimozide treatment of the negative schizophrenic syndrome: an open trial. J Clin Psychiatry 49 (6): 235–241
Fenton WS, McGlashan TH (1992) Testing systems for assessment of negative symptoms in schizophrenia. Arch Gen Psychiatry 49: 179–184
Goldberg S (1985) Negative and deficit symptoms in schizophrenia do respond to neuroleptics. Schizophr Bull 11: 352–456
Goldman RS, Tandon R (1989) Mutability and relationship between positive and negative symptoms during neuroleptic treatment in schizophrenia. Biol Psychiatry 25: 104A - 105A
Goldman RS, Tandon R, Goodson J (1989) Factor stability of positive and negative symptom ratings in schizophrenia. Biol Psychiatry 25: 103A - 104A
Heinrich K (1967) Zur Bedeutung des postremissiven Erschöpfungs-Syndroms für die Rehabilition Schizophrener. Nervenarzt 38: 487–491
Kane J, Honigfeld G, Singer J, Meltzer H (1988) Clozapine for the treatment-resistant schizophrenic. Arch Gen Psychiatry 45: 789–796
Kay SR, Lindenmayer JP (1991) Stability of psychopathology dimensions in chronic schizophrenia: response to clozapine treatment. Compr Psychiatry 32: 28–35
Kay SR, Fiszbein A, Opler LA (1987) The Positive and Negative Syndrome Scale ( PANSS) for schizophrenia. Schizophr Bull 13: 261–273
Leon J de, Wilson WH, Simpson GM (1989) Measurement of negative symptoms in schizophrenia. Psychiatr Dev 3: 211–234
Mackay A (1980) Positive and negative schizophrenic symptoms and the role of dopamine. Br J Psychiatry 137: 379–386
Marneros A, Deister A, Rohde A (1991) Long-term monomorphism of negative and positive schizophrenic episodes. In: Marneros A, Andreasen NC, Tsuang MT (eds) Negative versus positive schizophrenia. Springer, Berlin Heidelberg New York Tokyo, pp 183–196
Maurer K, Häfner H (1991) Dependence, independence or interdependence of positive and negative symptoms. In: Marneros A, Andreasen NC, Tsuang MT (eds) Negative versus positive schizophrenia. Springer, Berlin Heidelberg New York Tokyo, pp 160–182
Meltzer HY (1991) The effect of clozapine and other atypical antipsychotic drugs on negative symptoms. In: Marneros A, Andreasen NC, Tsuang MT (eds) Negative versus positive schizophrenia. Springer, Berlin Heidelberg New York Tokyo, pp 365–367
Meltzer HY, Zureick J (1989) Negative symptoms in schizophrenia: a target for new drug development. In: Dahl SG, Gram LF (eds) Clinical pharmacology in psychiatry. Psycho-pharmacology series, vol 7. Springer, Berlin Heidelberg New York Tokyo
Müller-Spahn F, Modell S, Thomma M (1992) Neue Aspekte in der Diagnostik, Pathogenese und Therapie schizophrener Minussymptomatik. Nervenarzt 63: 383–400
Niemeggers CJE, Awouters F, Janssen PAJ (1990) Pharmakologie der Neuroleptika und relevante Mechanismen zur Behandlung von Minussymptomatik. In: Möller HJ, Pelzer E (Hrsg) Neuere Ansätze zur Diagnostik und Therapie schizophrener Minussymptomatik. Springer, Berlin Heidelberg New York Tokyo, S 185–197
Ribeiro SCM, Tandon R, Goldman RS, Goodson J, Greden JF (1992) Covariance of positive and negative symptoms during initial neuroleptic treatment in schizophrenia. Biol Psychiatry 31: 81A
VanKammen DP, Hommer DW, Malas KL (1987) Effect of pimozide on positive and negative symptoms in schizophrenic patients: are negative symptoms state dependent? Neuropsychobiology 18: 113–117
Zinner HJ, Kraemer S, Möller HJ (1990) Empirische Untersuchungen zur Konkordanz verschiedener Minussymptomatik-Skalen sowie zur Korrelation mit testpsychologischen Befunden. In: Möller HJ, Pelzer E (Hrsg) Neuere Ansätze zur Diagnostik und Therapie schizophrener Minussymptomatik. Springer, Berlin Heidelberg New York Tokyo, S 59–68
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer-Verlag/Wien
About this chapter
Cite this chapter
Zinner, H.J., Fuger, J., Möller, HJ. (1994). Stabilität von Plus- und Minustyp unter neuroleptischer Behandlung. In: Möller, HJ., Laux, G. (eds) Fortschritte in der Diagnostik und Therapie schizophrener Minussymptomatik. Springer, Vienna. https://doi.org/10.1007/978-3-7091-9349-5_7
Download citation
DOI: https://doi.org/10.1007/978-3-7091-9349-5_7
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-82547-1
Online ISBN: 978-3-7091-9349-5
eBook Packages: Springer Book Archive